ORF73 LANA homologs of RRV and MneRV2 contain an extended RGG/RG-rich nuclear and nucleolar localization signal that interacts directly with importin β1 for non-classical nuclear import

The latency-associated nuclear antigens (LANA) of KSHV and macaque RFHVMn, members of the RV1 rhadinovirus lineage, are closely related with conservation of complex nuclear localization signals (NLS) containing bipartite KR-rich motifs and RG-rich domains, which interact distinctly with importins α...

Full description

Saved in:
Bibliographic Details
Published inVirology (New York, N.Y.) Vol. 511; pp. 152 - 164
Main Authors Howard, Kellie, Cherezova, Lidia, DeMaster, Laura K., Rose, Timothy M.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The latency-associated nuclear antigens (LANA) of KSHV and macaque RFHVMn, members of the RV1 rhadinovirus lineage, are closely related with conservation of complex nuclear localization signals (NLS) containing bipartite KR-rich motifs and RG-rich domains, which interact distinctly with importins α and ß1 for nuclear import via classical and non-classical pathways, respectively. RV1 LANAs are expressed in the nucleus of latently-infected cells where they inhibit replication and establish a dominant RV1 latency. Here we show that LANA homologs of macaque RRV and MneRV2 from the more distantly-related RV2 lineage, lack the KR-rich NLS, and instead have a large RG-rich NLS with multiple RG dipeptides and a conserved RGG motif. The RG-NLS interacts uniquely with importin β1, which mediates nuclear import and accumulation of RV2 LANA in the nucleolus. The alternative nuclear import and localization of RV2 LANA homologs may contribute to the dominant RV2 lytic replication phenotype. •LANA homologs of RRV and MneRV2 rhadinoviruses contain an N-terminal RGG/RG NLS.•The RGG/RG NLS motifs of RV2 LANA homologs interact with importin beta1.•RV2 LANAs are imported to the nucleus and nucleolus via the non-classical pathway.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present address: Covance, Redmond, WA, USA.
Present address: Juno Therapeutics, Inc., Seattle, WA, USA.
ISSN:0042-6822
1096-0341
DOI:10.1016/j.virol.2017.08.029